PARLIAMENTARY WRITTEN QUESTION
Clinical Priorities Advisory Group (19 October 2022)

The Clinical Priorities Advisory Group (CPAG) makes recommendations to NHS England on the relative priority for investment in new specialised treatments which have not received a technology appraisal from the National Institute for Health and Care Excellence. Funding to determine the number of new treatments which can be routinely commissioned is set annually as part of the overall specialised commissioning allocation process. In 2021/22 and 2022/23, £31 million was made available recurrently to support the CPAG’s recommendations. In 2020/21 different funding arrangements were put in place due to the temporary financial regime introduced during the pandemic.